
|Articles|June 19, 2017
Clinical Ink and Integron Partner to Streamline IoT-enabled Clinical Trials
Advertisement
Clinical Ink, provider of eSource and patient engagement technologies, and Integron, provider of managed services for the connected health and Internet of Things (IoT) industry, announced a partnership to extent Clinical Ink's capabilites in mobile device and sensor deployment, in order to engage and collect data from patients in clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Medidata, BioRender Announce New AI Partnerships Expanding Capabilities in Life Sciences
2
ACT Brief: Digital Consent, Global Diversity, and Clinical Setbacks Shape Today’s Clinical Research Landscape
3
Rethinking Trial Access in Lower-Income Regions Through Patient-Centric, AI-Driven Models
4
Bringing Clinical Trials Into the Digital Era with eConsent
5






.png)



.png)



.png)
.png)
